Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Low-Blast Count AML using Hypomethylating Agents.
De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT. De Bellis E, et al. Among authors: brescini m. Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28698788 Free PMC article. Review.
Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience.
Bruzzese A, Assanto GM, Diverio D, Quattrocchi L, Carmini D, La Rocca U, De Propris MS, Trisolini SM, Brescini M, Galassi G, Barberi W, Iori AP. Bruzzese A, et al. Among authors: brescini m. Bone Marrow Transplant. 2021 Jun;56(6):1455-1457. doi: 10.1038/s41409-020-01174-w. Epub 2021 Jan 29. Bone Marrow Transplant. 2021. PMID: 33514926 No abstract available.